---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-378487"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2026-09-01T20:30:50+00:00"
generated_at: "2026-09-01T20:32:13.711841+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ResMed enters $450M accelerated share repurchase with Citibank

## Summary
- ASR agreement with Citibank to repurchase $450M of common stock, funded by MatrixCare sale proceeds and cash.
- Payment of $450M on Sept 3, 2026; initial delivery of 80% of $450M / Sept 2 closing price.
- Final settlement expected December 2026 based on volume-weighted average price, with potential adjustments.
- Repurchase under existing 20M share authorization from Feb 2014; contemplated in FY27 guidance.

## SEC filing metadata
- accession: 0001193125-26-378487
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2026-09-01T20:30:50+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312526378487/0001193125-26-378487-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312526378487/d530283d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-378487
- JSON: https://secwatch.observer/filing/0001193125-26-378487.json
- Plain text: https://secwatch.observer/filing/0001193125-26-378487.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.